blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4326268

EP4326268 - TREATMENT OF CNS DISEASES WITH SGC STIMULATORS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  26.01.2024
Database last updated on 07.10.2024
FormerThe international publication has been made
Status updated on  28.10.2022
Formerunknown
Status updated on  13.05.2022
Most recent event   Tooltip21.05.2024Amendment by applicant 
Applicant(s)For all designated states
Tisento Therapeutics Inc.
245 First Street
Riverview II, 18th Floor
Cambridge, MA 02142 / US
[2024/09]
Inventor(s)01 / JIA, Lei
Cambridge, MA 02142 / US
02 / MERMERIAN, Ara
Cambridge, MA 02142 / US
03 / BARDEN, Timothy, Claude
Cambridge, MA 02142 / US
04 / LEE, Thomas, Wai-Ho
Cambridge, MA 02142 / US
05 / IYER, Karthik
Cambridge, MA 02142 / US
06 / RENNIE, Glen, Robert
Cambridge, MA 02142 / US
07 / IYENGAR, Rajesh, R.
Cambridge, MA 02142 / US
08 / JUNG, Joon
Cambridge, MA 02142 / US
09 / RENHOWE, Paul, Allan
Cambridge, MA 02142 / US
10 / CORREIA, Susana Dos, Santos
Cambridge, MA 02142 / US
11 / GERMANO, Peter
Cambridge, MA 02142 / US
 [2024/09]
Representative(s)Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
[2024/09]
Application number, filing date22721236.219.04.2022
[2024/09]
WO2022US25308
Priority number, dateUS202163177023P20.04.2021         Original published format: US 202163177023 P
US202163229251P04.08.2021         Original published format: US 202163229251 P
[2024/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022225902
Date:27.10.2022
Language:EN
[2022/43]
Type: A1 Application with search report 
No.:EP4326268
Date:28.02.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 27.10.2022 takes the place of the publication of the European patent application.
[2024/09]
Search report(s)International search report - published on:EP27.10.2022
ClassificationIPC:A61K31/4985, A61P25/28
[2024/09]
CPC:
A61K31/4985 (EP); A61K31/506 (US); A61P25/28 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/09]
Extension statesBA07.11.2023
ME07.11.2023
Validation statesKH07.11.2023
MA07.11.2023
MD07.11.2023
TN07.11.2023
TitleGerman:BEHANDLUNG VON ZNS-ERKRANKUNGEN MIT SGC-STIMULATOREN[2024/09]
English:TREATMENT OF CNS DISEASES WITH SGC STIMULATORS[2024/09]
French:TRAITEMENT DE MALADIES DU SNC AVEC DES STIMULATEURS DE SGC[2024/09]
Entry into regional phase07.11.2023National basic fee paid 
07.11.2023Designation fee(s) paid 
07.11.2023Examination fee paid 
Examination procedure07.11.2023Examination requested  [2024/09]
07.11.2023Date on which the examining division has become responsible
20.05.2024Amendment by applicant (claims and/or description)
Fees paidRenewal fee
07.11.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[ID]WO2019126354  (CYCLERION THERAPEUTICS INC [US]);
by applicantEP0667345
 DE19744026
 DE19830430
 WO0002851
 DE19834044
 DE19834047
 WO0027394
 DE19943635
 DE19942809
 WO03086407
 WO03095451
 WO2009032249
 WO2009094242
 US2009209556
 WO2010065275
 US2010216764
 WO2010099054
 US2010292192
 US2011118282
 US7947664
 US2011201621
 US2011218202
 WO2011119518
 US8053455
 WO2011149921
 WO2012058132
 US2013012511
 US2013072492
 US8420656
 US8455638
 US8507512
 US2013210798
 WO2015187470
 WO2016081668
 WO2017197555
 WO2017200825
 WO2018045276
 WO2019126354
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.